Back
Bumble, Inc. Vs. Novo Nordisk A/S Industry Stock Comparison
Sell
34
BMBL
Bumble, Inc.
Last Price:
$3.39
Seasonality Move:
-29.87%
Sell
36
NONOF
Novo Nordisk A/S
Last Price:
$50.52
Seasonality Move:
2.46%
Sell
34
Bumble, Inc. (BMBL)
is a Sell
Is Bumble, Inc. a Buy, Sell or Hold?
-
The current Bumble, Inc. [BMBL] share price is $3.39. The Score for BMBL is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
BMBL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Novo Nordisk A/S (NONOF)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NONOF] share price is $50.52. The Score for NONOF is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BMBL Stock Price Chart
What is Bumble, Inc.'s stock price today?
-
The Bumble, Inc. share price today is $3.39Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMBL is experiencing selling pressure, which indicates risk of future bearish movement.
NONOF Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $50.52Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMBL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 32.81 | Sell |
| Chaikin Money Flow: | -3715646 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.43 - 3.89) | Sell |
| Bollinger Bands (100): | (4.32 - 7.04) | Sell |
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.41 | Sell |
| Relative Strength Index (14 RSI): | 55.78 | Buy |
| Chaikin Money Flow: | 19812 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.49 - 48.99) | Buy |
| Bollinger Bands (100): | (47.93 - 58.53) | Sell |
BMBL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.68 | Sell |
| 20-day SMA: | 3.58 | Sell |
| 50-day SMA: | 4.58 | Sell |
| 200-day SMA: | 5.48 | Sell |
| 8-day EMA: | 3.64 | Sell |
| 20-day EMA: | 3.79 | Sell |
| 50-day EMA: | 4.46 | Sell |
| 200-day EMA: | 5.82 | Sell |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.16 | Buy |
| 20-day SMA: | 47.71 | Buy |
| 50-day SMA: | 51.14 | Sell |
| 200-day SMA: | 61.76 | Sell |
| 8-day EMA: | 48.52 | Buy |
| 20-day EMA: | 48.38 | Buy |
| 50-day EMA: | 50.49 | Buy |
| 200-day EMA: | 63.74 | Sell |
Bumble, Inc. Earnings Growth & BMBL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $1.42 per share.
Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Bumble, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||